‼️ #ESMO26 simultaneous publication by Gross, et al.

A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II–IV Cutaneous Squamous Cell Carcinoma: Final Analysis.

Read full publication: https://bit.ly/4zRCM3C